Hyperprolactinemia and galactorrhea with standard-dose famotidine therapy.
Güven
K
K
Kelestimur
F
F
D000328:Adult; D000897:Anti-Ulcer Agents / Q000009:adverse effects* / Q000627:therapeutic use; D004381:Duodenal Ulcer / Q000188:drug therapy; D015738:Famotidine / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D005687:Galactorrhea / Q000139:chemically induced*; D006801:Humans; D006966:Hyperprolactinemia / Q000139:chemically induced*
D000897:Anti-Ulcer Agents; D015738:Famotidine